Overview
The recent nationwide cross‑sectional study from Denmark examined the safety profile of the Precice Stryde limb lengthening nail. Researchers evaluated 30 bone segments in 27 patients and discovered a high prevalence of delayed pain, osteolysis, periosteal reaction, and cortical hypertrophy around the nail’s telescoping junction. This information is crucial for anyone considering or currently undergoing limb lengthening with the STRYDE system, as it directly influences postoperative monitoring and timing of implant removal.
Understanding these findings helps patients recognize warning signs early, discuss surveillance strategies with their surgeon, and make informed decisions about the duration of implant retention. The study highlights that, unlike earlier generation devices, the STRYDE nail may be associated with unique late‑stage complications that require vigilant follow‑up.
What This Study Examined
Investigators performed radiographic reviews of all treated bone segments in February 2021, looking for late‑onset pain and specific radiographic changes—osteolysis, periosteal reaction, and cortical hypertrophy—at the telescoping interface of the STRYDE nail. They also noted any discoloration of removed nails that could suggest corrosion.
Why This Matters for Patients
Late‑stage pain can be the first clinical clue that bone is reacting adversely to the implant. Early detection of osteolysis or periosteal reaction allows surgeons to intervene before structural compromise occurs, potentially preventing fracture or the need for more extensive revision surgery.
Medical Background
Limb lengthening is a surgical technique used to correct discrepancies in leg length or to achieve height increase. The process relies on distraction osteogenesis, where an osteotomy (controlled bone cut) creates two segments that are gradually pulled apart. The gap fills with new bone, called the regenerate. Modern technology has shifted from external fixators to fully implantable intramedullary nails such as the STRYDE system.
How the Procedure Works
During surgery, the orthopedic surgeon makes an osteotomy in the target bone (typically femur or tibia) and inserts the telescoping STRYDE nail into the medullary canal. A magnetic remote controller incrementally lengthens the nail, usually at 0.5–1 mm per day, while the surrounding soft tissues adapt. The patient monitors progress with a smartphone app that records distraction length and rate. After reaching the planned length, the nail is locked, allowing the regenerate to consolidate before the device is removed.
Who Is a Candidate?
Ideal candidates are skeletally mature adolescents or adults with a limb‑length discrepancy of at least 2 cm, good bone quality, and compliance with postoperative protocols. Contraindications include active infection, severe osteoporosis, or medical conditions that impair bone healing (e.g., uncontrolled diabetes).
Clinical Summary
- Procedure: Intramedullary limb lengthening with the Precice Stryde nail
- Typical Duration: Distraction phase 3‑6 months; consolidation 3‑12 months
- Recovery: Partial weight‑bearing begins 1‑2 weeks post‑op; full weight‑bearing after radiographic confirmation of regenerate
- Success Rate (general): 85‑95 % achieve intended length with acceptable functional outcome when protocols are followed
Study Methodology
The investigators conducted a cross‑sectional analysis of all patients in Denmark who received a STRYDE nail between 2016 and 2020. Radiographs were reviewed in February 2021, providing a minimum follow‑up of several months to over two years for each case. The design was descriptive, aiming to determine the prevalence of specific adverse radiographic findings.
Patient Selection Criteria
All 27 patients (30 bone segments) who had a STRYDE nail implanted and were still under clinical care in Denmark were included. No patients were excluded, ensuring a real‑world representation of outcomes across femur and tibia sites.
Outcome Measures
Primary outcomes were the presence of (1) late‑onset pain after the consolidation phase, (2) radiographically confirmed osteolysis, (3) periosteal reaction (especially multilayered), and (4) cortical hypertrophy at the nail’s telescoping junction. Secondary observations included nail discoloration suggestive of corrosion and the proportion of nails still in situ at the time of review.
Results & Findings
Among the 30 bone segments, 21 (70 %) displayed radiographic changes. Specific findings were:
- Osteolysis in 19 segments (63 %)
- Periosteal reaction in 12 segments (40 %); most often multilayered
- Cortical hypertrophy in 12 segments (40 %)
Eight patients reported late‑onset pain, which often preceded the radiographic abnormalities, suggesting it may be an early clinical warning sign. Discoloration at the nail interface—potentially indicating corrosion—was observed in several explanted devices. At the time of review, 15 nails remained implanted, indicating they were still at risk for developing the described complications.
Key Outcomes
The study demonstrates a high incidence of osteolysis and periosteal reaction associated with the STRYDE nail, especially after the regenerate has entered the consolidation phase. Pain emerging at this late stage should prompt immediate imaging to assess for these changes.
Complications & Risks
- Late‑onset pain during consolidation
- Osteolysis (bone loss) around the telescoping zone
- Periosteal reaction, often multilayered, indicating inflammation of the periosteum
- Cortical hypertrophy (abnormal bone thickening) at the nail junction
- Potential corrosion of the nail leading to discoloration and metal‑related irritation
- Risk of fracture if osteolysis progresses unchecked
- Need for earlier device removal than originally planned
(Source: PubMed / Europe PMC)
Key Takeaways for Patients
- Late pain after the distraction phase is not normal; contact your surgeon immediately.
- Regular X‑rays are essential even after you think the bone has healed.
- Signs of osteolysis or periosteal reaction may require early removal of the STRYDE nail.
- Discuss the timing of nail removal with your surgeon; waiting too long can increase the risk of bone loss.
- Ask your surgeon whether your implant shows any discoloration that could suggest corrosion.
Frequently Asked Questions
- What symptoms should prompt me to call my surgeon after limb lengthening?
- Any new or worsening pain after the distraction phase, especially if it occurs when the bone should be consolidating, should be reported promptly. Swelling, redness, or a feeling of instability are also warning signs.
- How is osteolysis detected on X‑ray?
- Osteolysis appears as a loss of normal bone density around the nail, often visualized as a dark, radiolucent area near the telescoping junction.
- Can the STRYDE nail be removed before the regenerate is fully mature?
- Yes, if imaging shows significant osteolysis, periosteal reaction, or early pain, removal may be advised even before complete consolidation to prevent fracture.
- Is corrosion of the nail dangerous?
- Corrosion may release metal ions that irritate surrounding tissue and contribute to bone loss. It is a reason for early explantation when observed.
- Will I need additional surgery after the nail is removed?
- In most cases, once the nail is removed after adequate bone healing, no further surgery is required. However, if osteolysis is extensive, additional bone grafting may be necessary.